sion and doubt about our products.
Think it couldn’t happen to us?
—Frank Lampe, Vice President, Communications & Industry
Relations, United Natural Products Alliance
As we approach the end of 2016, the state
of the dietary supplement industry is strong.
CRN’s annual consumer survey revealed an increase in usage, with 71% of Americans (more
than 170 million) taking dietary supplements.
Sales growth continues at a rate outpacing
other consumer products, and categories like
probiotics, protein and herbals are showing particularly strong
When we look back, we’ll view 2016 as a year in which the
industry took the initiative to improve its accountability and increase its transparency. CRN played a major role in this evolution
with development of the Supplement OWL, the online dietary
supplement product registry. This potentially transformative
project demonstrates the eagerness of companies to give regulators, retailers and consumers the information and tools they
need to identify and evaluate products, labels and ingredients.
Other initiatives, like the American Herbal Products Association (AHPA)-led botanical raw materials GMPs and the Global
Retailer and Manufacturer Alliance (GRMA) common standard
for GMP inspections, also illustrate that supplement manufacturers want to reassure their customers about the quality of their
products. Even from a regulatory standpoint, this year has been
one of forward movement. Creation of the new Office of Dietary
Supplements at FDA assures more attention and higher priority
for supplement issues at the agency. The FDA’s revised NDI draft
guidance, though far from perfect, furthers the dialogue. Progress
has been made. As we look ahead to 2017, uncertainty about the
regulatory environment exists, but our accomplishments in 2016
place us in a stronger position to address those challenges.
—Steve Mister, President & CEO,
Council for Responsible Nutrition (CRN)
This past year has been one of great impact.
We learned the dietary supplement industry is a
major economic engine. We saw increased usage with more than 170 million Americans taking dietary supplements each year. We experienced progress with the release of the NDI draft
guidance, and a step toward increased trust and
transparency with the development of the industry’s new product registry, the Supplement OWL. These milestones were not
achieved overnight. They were gradual accomplishments of a
collaborative process, one that must continue into 2017. This requires ambition.
When I started as chair of CRN’s Board of Directors two years
ago, there was great ambition at CRN to build consensus and
momentum, and as I wrap up my tenure, the ambition remains.
Through its work with regulators in the states and overseas, relationships with the media, engagement with the scientific com-